COMMUNITY ONCOLOGISTS' CLINICAL TRIALS EDUCATION PROGRAM

加州大学圣迭戈分校癌症中心是加州大学圣迭戈分校的一个有组织的研究单位。包括 在15个大学院系的120名成员中，它位于加州大学洛杉矶分校医学院 圣地亚哥市中心附近的中心以及洛杉矶的加州大学圣迭戈分校校园 乔拉。它的任务是减少癌症的发病率和发病率， 南加州癌症死亡率。加州大学圣迭戈分校癌症中心是 大学范围内癌症项目整合的研究部分 研究、教学和病人护理。癌症中心已经连续进行了 自1979年4月1日起作为NCI指定的癌症中心提供资金 以优秀的基础研究为导向，强调翻译 研究。每年有500多名患者接受临床治疗； 其中一半以上是基于机构协议的。 全国范围内临床试验的低应收率被认为是 在诊断方面取得预期的快速进展的主要障碍 以及癌症的治疗。此外，妇女的临床试验也会产生收益 少数群体的成员比以往任何时候都更难实现。 加州大学圣地亚哥分校开发并试行了一项由两部分组成的外展计划，旨在 帮助社区肿瘤医生提高转诊到临床的比率 试验研究。 该计划现已准备好在社区范围内进行扩展和测试 申请。该计划的第一部分是一个旨在 增加社区肿瘤学家对以下项目的了解和参与 临床试验研究。它包括针对以下目标的信息和技术 帮助社区肿瘤学家克服一些主要障碍 转介患者进行临床试验，如知情同意、时间 令人费解的解释，以及语言和文化障碍 病人。第二部分重点介绍了UCSD的扩展和增强 癌症中心的临床试验信息系统。它的设计目的是 帮助社区肿瘤学家克服他们面临的其他重大障碍 在决定是否将患者转介给临床试验时，例如LASK 信息的丢失、失控和患者对被转诊人的失去 临床试验。虽然希望移除所有人都是不现实的 临床试验转诊的障碍可以通过一种努力来实现，这 教育计划旨在消除或至少减少许多 医生遇到的最重要的障碍，随后是 他们的病人。

The UCSD Cancer Center is an Organized Research Unit of UCSD. Comprised of 120 members in 15 University Departments, it is located at UCSD Medical Center near downtown San Diego as well as at the campus of UCSD in La Jolla. Its mission is to reduce the incidence of and morbidity and mortality from cancer in southern California. UCSD Cancer Center is the research component of a University-wide cancer program integrating research, teaching and patient care. The Cancer Center has had continuous funding as an NCI designated Cancer Center since April 1, 1979 and is oriented toward excellent basic research with an emphasis on translational research. Over 500 patients are placed on clinical protocols annually; more than half of these on institutional protocols. The low accrual rates nationwide to clinical trials is recognized as a major hindrance to achieving the rapid progress desired in the diagnosis and treatment of cancer. In addition, accrual to clinical trials by women and members of minority groups has been ever more difficult to achieve. UCSD developed and pilot tested a two part outreach program aimed at helping community oncologists increase their rate of referrals to clinical trials research. This program is now ready for expansion and testing in a community-wide application. Part one of the program is an educational component aimed at increasing community oncologists' knowledge of, and participation in, clinical trials research. It includes information and techniques aimed at helping community oncologists overcome some of the major barriers to referring patients to clinical trials, such as informed consent, time consuming explanations, and language and cultural barriers with their patients. Part two focuses on the expansion and enhancement of UCSD Cancer Center's Clinical Trials Information System. It is designed to help community oncologists overcome other significant barriers they face when deciding whether to refer patients to clinical trials, such as lack of information, loss of control, and loss of their patient to the referred clinical trial. While it is unrealistic to hope that the removal of all barriers to clinical trials referrals can be achieved by one effort, this educational program is designed to remove, or at least reduce, many of the most significant barriers experienced by physicians, and subsequently, by their patients.